How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?
Journal
Journal of the Formosan Medical Association
Journal Volume
110
Journal Issue
2
Pages
67-69
Date Issued
2011
Author(s)
SDGs
Other Subjects
antibiotic agent; Pneumococcus vaccine; antibiotic resistance; cost benefit analysis; drug efficacy; human; immunity; incidence; lobar pneumonia; note; prevalence; serotype; Streptococcus pneumonia; vaccination; world health organization
Publisher
Elsevier B.V.
Type
note